Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Kenakin

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
British Journal of Pharmacology|July 2, 2010
Being mindful of seven-transmembrane receptor 'guests' when assessing agonist selectivityTerry Kenakin
Journal of Receptor and Signal Transduction Research|September 23, 2010
G protein coupled receptors as allosteric proteins and the role of allosteric modulatorsTerry Kenakin
Molecular Pharmacology|January 20, 2018
Is the Quest for Signaling Bias Worth the Effort?Terry Kenakin
Receptors & Channels|June 19, 2004
G-protein coupled receptors as allosteric machinesTerry Kenakin
Molecular Pharmacology|January 15, 2004
Efficacy as a vector: the relative prevalence and paucity of inverse agonismTerry Kenakin
Molecular Pharmacology|September 29, 2007
Functional selectivity through protean and biased agonism: who steers the ship?Terry Kenakin
Nature Reviews. Drug Discovery|May 31, 2003
Predicting therapeutic value in the lead optimization phase of drug discoveryTerry Kenakin
Nature Reviews. Drug Discovery|November 3, 2005
New concepts in drug discovery: collateral efficacy and permissive antagonismTerry Kenakin
Progress in Molecular Biology and Translational Science|February 19, 2013
Allosteric drug. PrefaceTerry Kenakin
Journal of Theoretical Biology|July 30, 2019
G-Protein/Receptor inhibitors as blockers of receptor signalingTerry Kenakin
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
British Journal of Pharmacology|July 2, 2010
Being mindful of seven-transmembrane receptor 'guests' when assessing agonist selectivityTerry Kenakin
Journal of Receptor and Signal Transduction Research|September 23, 2010
G protein coupled receptors as allosteric proteins and the role of allosteric modulatorsTerry Kenakin
Molecular Pharmacology|January 20, 2018
Is the Quest for Signaling Bias Worth the Effort?Terry Kenakin
Receptors & Channels|June 19, 2004
G-protein coupled receptors as allosteric machinesTerry Kenakin
Molecular Pharmacology|January 15, 2004
Efficacy as a vector: the relative prevalence and paucity of inverse agonismTerry Kenakin
Molecular Pharmacology|September 29, 2007
Functional selectivity through protean and biased agonism: who steers the ship?Terry Kenakin
Nature Reviews. Drug Discovery|May 31, 2003
Predicting therapeutic value in the lead optimization phase of drug discoveryTerry Kenakin
Nature Reviews. Drug Discovery|November 3, 2005
New concepts in drug discovery: collateral efficacy and permissive antagonismTerry Kenakin
Progress in Molecular Biology and Translational Science|February 19, 2013
Allosteric drug. PrefaceTerry Kenakin
Journal of Theoretical Biology|July 30, 2019
G-Protein/Receptor inhibitors as blockers of receptor signalingTerry Kenakin
Pageof 12